comparemela.com

Latest Breaking News On - Natalie rittenhouse - Page 1 : comparemela.com

Study may explain why high-sugar diets can worsen IBD

Excess sugar hampers cells that renew the colon s lining in a mouse model of inflammatory bowel disease (IBD), according to a new study that could help get to the bottom of why limiting sugary foods can ease symptoms for patients with IBD.

Study could help understand why limiting sugary foods can ease symptoms for IBD patients

Excess sugar hampers cells that renew the colon's lining in a mouse model of inflammatory bowel disease (IBD), according to a new study by University of Pittsburgh scientists.

Study may explain why high-sugar diets can wo

Excess sugar hampers cells that renew the colon’s lining in a mouse model of inflammatory bowel disease (IBD), according to a new study by University of Pittsburgh scientists that could help get to the bottom of why limiting sugary foods can ease symptoms for patients with IBD.

Cancer Tricks Immune Cells, Immunotherapy Can Take Advantage

Cancer Tricks Immune Cells, Immunotherapy Can Take Advantage A paper published today in Nature shows how chemicals in the areas surrounding tumors known as the tumor microenvironment subvert the immune system and enable cancer to evade attack. These findings suggest that an existing drug could boost cancer immunotherapy. The study was conducted by a team of scientists at the University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center, led by Pitt associate professor of immunology Greg Delgoffe. By disrupting the effect of the tumor microenvironment on immune cells in mice, the researchers were able to shrink tumors, prolong survival and increase sensitivity to immunotherapy.

Insight about tumor microenvironment could boost cancer immunotherapy

 E-Mail IMAGE: Cancer evades the immune system by feeding the T cells that protect the tumor and starving the T cells that would attack. view more  Credit: UPMC, created with BioRender.com PITTSBURGH, Feb. 15, 2021 - A paper published today in Nature shows how chemicals in the areas surrounding tumors known as the tumor microenvironment subvert the immune system and enable cancer to evade attack. These findings suggest that an existing drug could boost cancer immunotherapy. The study was conducted by a team of scientists at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine, led by Greg Delgoffe, Ph.D., Pitt associate professor of immunology. By disrupting the effect of the tumor microenvironment on immune cells in mice, the researchers were able to shrink tumors, prolong survival and increase sensitivity to immunotherapy.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.